A team at the Johns Hopkins Bloomberg School of Public Health has described a reduction in the use of diabetic medications following bariatric surgery which does not correlate with the gradual weight loss observed. The researchers propose that this effect is mediated by gastric hormones, and go on to examine the associated healthcare costs.

Full article